Useful For

Only orderable as a reflex. For more information see:

AIAES / Axonal Neuropathy, Autoimmune/Paraneoplastic Evaluation, Serum

DMS2 / Dementia, Autoimmune/Paraneoplastic Evaluation, Serum

DYS2 / Dysautonomia, Autoimmune/Paraneoplastic Evaluation, Serum

ENS2 / Encephalopathy, Autoimmune/Paraneoplastic Evaluation, Serum

EPS2 / Epilepsy, Autoimmune/Paraneoplastic Evaluation, Serum

GID2 / Gastrointestinal Dysmotility, Autoimmune/Paraneoplastic Evaluation, Serum

MAS1 / Myelopathy, Autoimmune/Paraneoplastic Evaluation, Serum

MDS2 / Movement Disorder, Autoimmune/Paraneoplastic Evaluation, Serum

PCDES / Pediatric Autoimmune Encephalopathy/CNS Disorder Evaluation, Serum

Serological evaluation of patients who present with a subacute neurological disorder of undetermined etiology, especially those with risk factors for primary lung carcinoma

Directing a focused search for cancer

Investigating neurological symptoms that appear during, or after, cancer therapy, and are not explainable my metastasis

Reporting an end titer result from serum specimens